Immuneering Corp filed 1 current report with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-06-15. Between them they name 1 person. Each change below is quoted from the filing and linked to it.
Every change, newest first
Appointed: Andrew Gengos, Chief Financial Officer
On June 11, 2026, the Board of Directors (the "Board") of Immuneering Corporation (the "Company") appointed Andrew Gengos as th e Chief Financial Officer and Treasurer of t he Company, to become effective on the commencement of his employment with the Company, which is expected to be on or before July 16, 2026 (the date Mr. Gengos actually commences employment with the Company, the "Effective Date").
Appointed: Andrew Gengos
The Board also designated Mr. Gengos as the Company's principal financial officer as of the Effective Date, succeeding Mallory Morales in such role.
Find people with the same kind of experience as the Chief Financial Officer at Immuneering Corp, with the record behind each one.
Find candidates like Chief Financial Officer at Immuneering CorpNew leaders review vendors and budgets in their first months. Get an alert the next time Immuneering Corp is in the news or changes leadership.
Get an alert when Immuneering Corp changes leadershipTools for this story
Each opens in a new tab, filled in for Immuneering Corp. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.